×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Allogene Therapeutics Inc. (ALLO) NASDAQ

$4.47 0.01 (0.22%)

Market Cap: $755.84M

As of 03/28/24 04:00 PM EDT. Market closed.

(ALLO)

Allogene Therapeutics Inc. (ALLO)
NASDAQ

$4.47
0.01 (0.22%)

Market Cap: $755.84M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

allogene therapeutics is a biotechnology company with a mission to catalyze the next revolution in cancer treatment through the development of allogeneic chimeric antigen receptor t-cell (car t) therapy directed at blood cancers and solid tumors. founded and led by former kite pharma executives who bring unrivaled clinical development acumen in cell therapy, allogene is well-positioned to further ... read more

allogene therapeutics is a biotechnology company with a mission to catalyze the next revolution in cancer treatment through the development of allogeneic chimeric antigen receptor t-cell (car t) therapy directed at blood cancers and solid tumors. founded and led by former kite pharma executives who bring unrivaled clinical development acumen in cell therapy, allogene is well-positioned to further the potential of allogeneic cell therapy for patients. allogeneic car t therapies are engineered from cells of healthy donors and stored for “off-the-shelf” use in patients. this approach eliminates the need to create personalized therapy from a patient’s own cells, simplifies manufacturing, and reduces the time patients must wait for car t treatment. the allogene portfolio includes 16 pre-clinical t cell therapy assets and ucart19, an allogeneic car t therapy currently in phase 1 development for the treatment of acute lymphoblastic leukemia (all). through its notable partnerships, allogene le read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO Compensation (Total)
$3.59M
Address
.
PRICE CHART FOR ALLOGENE THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.43
Previous Close
$4.46
Days Range
$4.15 - $4.63
52 week range
$2.23 - $6.89
Volume
1,377,673
Avg. Volume (30 days)
2,721,540
Market Cap
$755.84M
Dividend Yield
-
P/E
(2.31)
Shares Outstanding
169,091,992
Open
$4.43
Previous Close
$4.46
Days Range
$4.15 - $4.63
52 week range
$2.23 - $6.89
Volume
1,377,673
Avg. Volume (30 days)
2,721,540
Market Cap
$755.84M
Dividend Yield
-
P/E
(2.31)
Shares Outstanding
169,091,992
FINANCIAL STATEMENTS FOR ALLOGENE THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ALLOGENE THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Chang David DPresident and CEOMar 14, 2024 Option Exercise$4.3353,393231,1924,465,278Mar 18, 2024, 08:10 PM
Parker Geoffrey M.CHIEF FINANCIAL OFFICERJan 30, 2024 Buy$3.60190683819,590Mar 06, 2024, 09:52 PM
Roberts ZacharyEVP of R&DJan 22, 2024 Option Exercise$3.1724,69078,376375,253Jan 24, 2024, 05:25 PM
MESSEMER DEBORAH M.DirectorDec 18, 2023 Sale$2.7018,64050,31762,456Dec 20, 2023, 04:26 PM
Mayo StephenDirectorAug 07, 2023 Sale$4.2910,00042,85525,328Aug 09, 2023, 04:07 PM
Chang David DPresident and CEOMar 14, 2023 Option Exercise$5.5622,340124,2102,269,447Mar 16, 2023, 05:32 PM
SCHMIDT ERIC THOMASChief Financial OfficerMar 14, 2023 Option Exercise$5.4735,879196,258304,345Mar 16, 2023, 05:08 PM
MOORE ALISONChief Technical OfficerMar 14, 2023 Option Exercise$5.518,35145,990114,637Mar 16, 2023, 04:49 PM
Bhavnagri VeerGeneral CounselMar 14, 2023 Option Exercise$5.6723,628133,971556,049Mar 16, 2023, 04:46 PM
Bhavnagri VeerGeneral CounselFeb 13, 2023 Sale$6.853,00020,550577,677Feb 14, 2023, 05:10 PM
Bhavnagri VeerGeneral CounselJan 17, 2023 Sale$7.043,00021,120580,677Jan 18, 2023, 06:10 PM
Bhavnagri VeerGeneral CounselDec 15, 2022 Sale$7.535,60242,186583,677Dec 19, 2022, 04:29 PM
Amado RafaelEVP of R&DOct 07, 2022 Option Exercise$11.838,464100,099541,946Oct 11, 2022, 04:35 PM
Amado RafaelEVP of R&DOct 03, 2022 Option Exercise$11.068,96899,201531,290Oct 05, 2022, 04:02 PM
WITTE OWEN N.DirectorAug 12, 2022 Sale$17.255,00086,250218,271Aug 15, 2022, 05:40 PM
WITTE OWEN N.DirectorAug 11, 2022 Sale$16.5010,000165,000223,271Aug 15, 2022, 05:40 PM
WITTE OWEN N.DirectorAug 12, 2022 Sale$17.255,00086,250218,271Aug 15, 2022, 05:12 PM
WITTE OWEN N.DirectorAug 11, 2022 Sale$16.5010,000165,000223,271Aug 15, 2022, 05:12 PM
Amado RafaelEVP of R&D and CMOAug 02, 2022 Sale$11.972,00023,940540,257Aug 02, 2022, 05:40 PM
Amado RafaelEVP of R&D and CMOJul 05, 2022 Sale$11.442,00022,880542,257Jul 06, 2022, 04:16 PM
WITTE OWEN N.DirectorJun 22, 2022 Sale$11.7610,000117,600233,271Jun 23, 2022, 04:40 PM
Amado RafaelEVP of R&D and CMOJun 21, 2022 Sale$11.182,00022,360544,257Jun 22, 2022, 04:47 PM
Amado RafaelEVP of R&D and CMOMay 19, 2022 Sale$7.4011,50085,092546,257May 19, 2022, 05:40 PM
Amado RafaelEVP of R&D and CMOMar 15, 2022 Sale$7.715,16939,848320,119Mar 17, 2022, 05:59 PM
Bhavnagri VeerGeneral CounselMar 15, 2022 Sale$7.688,84967,962413,841Mar 17, 2022, 05:59 PM
Chang David DPresident and CEOMar 15, 2022 Sale$7.6523,648180,8792,289,652Mar 17, 2022, 05:59 PM
SCHMIDT ERIC THOMASChief Financial OfficerMar 15, 2022 Sale$7.6311,46987,551100,546Mar 17, 2022, 05:58 PM
MOORE ALISONChief Technical OfficerMar 15, 2022 Sale$7.638,69866,388120,430Mar 17, 2022, 05:58 PM
Kazam Joshua ADirectorJan 12, 2022 Buy$12.6015,000189,000258,885Jan 14, 2022, 02:13 PM
Belldegrun ArieDirectorJan 12, 2022 Buy$12.60155,0391,953,491195,039Jan 14, 2022, 12:02 PM
Amado RafaelEVP of R&D and CMOOct 01, 2021 Sale$24.3511,507280,185323,928Oct 04, 2021, 05:55 PM
Bhavnagri VeerGeneral CounselSep 15, 2021 Option Exercise$2.275,00011,350426,669Sep 17, 2021, 04:44 PM
Bhavnagri VeerGeneral CounselSep 15, 2021 Sale$24.775,000123,844421,669Sep 17, 2021, 04:44 PM
WITTE OWEN N.DirectorSep 09, 2021 Sale$25.545,000127,700221,182Sep 09, 2021, 05:32 PM
WITTE OWEN N.DirectorAug 20, 2021 Sale$23.4710,000234,700231,182Aug 23, 2021, 04:22 PM
Bhavnagri VeerGeneral CounselAug 16, 2021 Option Exercise$2.275,00011,350426,353Aug 17, 2021, 04:05 PM
Bhavnagri VeerGeneral CounselAug 16, 2021 Sale$21.005,000104,994421,353Aug 17, 2021, 04:05 PM
Bhavnagri VeerGeneral CounselJul 15, 2021 Option Exercise$2.275,00011,350426,353Jul 16, 2021, 04:14 PM
Bhavnagri VeerGeneral CounselJul 15, 2021 Sale$21.555,000107,753421,353Jul 16, 2021, 04:14 PM
WITTE OWEN N.DirectorJun 09, 2021 Sale$25.059,969249,723236,182Jun 11, 2021, 05:48 PM
SCHMIDT ERIC THOMASChief Financial OfficerMay 24, 2021 Option Exercise$18.2214,897271,423110,994May 26, 2021, 08:00 AM
Belldegrun ArieDirectorMay 24, 2021 Option Exercise$18.22379,0666,906,582583,034May 25, 2021, 08:00 AM
Amado RafaelEVP of R&D and CMOMar 15, 2021 Sale$38.052,798106,471110,035Mar 17, 2021, 05:01 PM
Chang David DPresident and CEOMar 15, 2021 Sale$38.5720,513791,2712,204,417Mar 17, 2021, 05:00 PM
MOORE ALISONChief Technical OfficerMar 15, 2021 Sale$38.146,164235,089102,574Mar 17, 2021, 05:00 PM
Bhavnagri VeerGeneral CounselMar 15, 2021 Option Exercise$2.2710,00022,700415,774Mar 17, 2021, 05:00 PM
Bhavnagri VeerGeneral CounselMar 15, 2021 Sale$37.9516,623630,798409,151Mar 17, 2021, 05:00 PM
SCHMIDT ERIC THOMASChief Financial OfficerMar 15, 2021 Sale$38.238,053307,88971,231Mar 17, 2021, 05:00 PM
SCHMIDT ERIC THOMASChief Financial OfficerJan 15, 2021 Sale$32.2615,000483,8591,164,048Jan 19, 2021, 04:31 PM
SCHMIDT ERIC THOMASChief Financial OfficerJan 14, 2021 Sale$30.7715,000461,6101,172,744Jan 19, 2021, 04:31 PM
Bhavnagri VeerGeneral CounselDec 17, 2020 Option Exercise$2.2751,500116,905405,402Dec 18, 2020, 04:34 PM
SCHMIDT ERIC THOMASChief Financial OfficerNov 16, 2020 Sale$32.8815,000493,1461,192,961Nov 18, 2020, 04:36 PM
SCHMIDT ERIC THOMASChief Financial OfficerOct 15, 2020 Sale$40.4915,000607,3921,207,491Oct 16, 2020, 06:55 PM
MOORE ALISONChief Technical OfficerOct 12, 2020 Option Exercise$2.2724,23355,009132,603Oct 13, 2020, 04:34 PM
MOORE ALISONChief Technical OfficerOct 13, 2020 Option Exercise$2.2711,03125,040119,401Oct 13, 2020, 04:34 PM
MOORE ALISONChief Technical OfficerOct 13, 2020 Sale$42.0011,031463,302108,370Oct 13, 2020, 04:34 PM
MOORE ALISONChief Technical OfficerOct 12, 2020 Sale$42.0024,2331,017,786108,370Oct 13, 2020, 04:34 PM
MOORE ALISONChief Technical OfficerOct 09, 2020 Option Exercise$2.2730,19968,552147,879Oct 09, 2020, 05:49 PM
MOORE ALISONChief Technical OfficerOct 08, 2020 Option Exercise$2.275,06511,498122,745Oct 09, 2020, 05:49 PM
MOORE ALISONChief Technical OfficerOct 09, 2020 Sale$41.0039,5091,619,869108,370Oct 09, 2020, 05:49 PM
MOORE ALISONChief Technical OfficerOct 08, 2020 Sale$41.005,065207,665117,680Oct 09, 2020, 05:49 PM
Amado RafaelEVP of R&D and CMOOct 07, 2020 Sale$39.4016,538651,515111,677Oct 08, 2020, 05:10 PM
MOORE ALISONChief Technical OfficerOct 06, 2020 Option Exercise$2.2735,26480,049161,536Oct 08, 2020, 05:03 PM
MOORE ALISONChief Technical OfficerOct 06, 2020 Sale$40.0044,5741,782,960117,680Oct 08, 2020, 05:03 PM
Bhavnagri VeerGeneral CounselOct 06, 2020 Option Exercise$2.2710,00022,700363,902Oct 08, 2020, 05:01 PM
Bhavnagri VeerGeneral CounselOct 06, 2020 Sale$40.0010,000400,000353,902Oct 08, 2020, 05:01 PM
Bhavnagri VeerGeneral CounselOct 01, 2020 Option Exercise$2.2725,00056,750378,902Oct 02, 2020, 04:42 PM
Bhavnagri VeerGeneral CounselOct 01, 2020 Sale$36.5225,000912,913362,687Oct 02, 2020, 04:42 PM
Amado RafaelEVP of R&D and CMOOct 01, 2020 Sale$36.379,752354,662128,215Oct 02, 2020, 04:40 PM
SCHMIDT ERIC THOMASChief Financial OfficerSep 21, 2020 Sale$35.3015,000529,5451,217,706Sep 22, 2020, 04:48 PM
Bhavnagri VeerGeneral CounselSep 01, 2020 Option Exercise$2.2725,00056,750378,902Sep 03, 2020, 04:12 PM
Bhavnagri VeerGeneral CounselSep 01, 2020 Sale$35.3625,000883,966354,302Sep 03, 2020, 04:12 PM
MOORE ALISONChief Technical OfficerAug 13, 2020 Option Exercise$2.2732,45173,664126,272Aug 14, 2020, 04:04 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerAug 07, 2020 Sale$37.4113,291497,23618,723,992Aug 10, 2020, 04:34 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerAug 06, 2020 Sale$37.5024,154905,79418,749,151Aug 10, 2020, 04:34 PM
Bhavnagri VeerGeneral CounselAug 03, 2020 Option Exercise$2.2725,00056,750385,455Aug 05, 2020, 05:09 PM
Bhavnagri VeerGeneral CounselAug 03, 2020 Sale$36.8931,5531,164,121370,352Aug 05, 2020, 05:09 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 30, 2020 Sale$42.2159,7472,522,05219,716,306Jun 30, 2020, 04:53 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 29, 2020 Sale$43.2724,9041,077,54419,776,053Jun 30, 2020, 04:53 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 26, 2020 Sale$44.0150022,00519,800,957Jun 30, 2020, 04:53 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 24, 2020 Sale$43.9315,269670,71419,873,816Jun 25, 2020, 06:24 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 23, 2020 Sale$43.98132,2255,814,61019,911,298Jun 25, 2020, 06:24 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 25, 2020 Sale$44.1972,3593,197,32719,801,457Jun 25, 2020, 06:24 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 22, 2020 Sale$42.83172,4257,384,72120,064,165Jun 22, 2020, 06:25 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 19, 2020 Sale$42.0447,7672,008,30620,193,735Jun 22, 2020, 06:25 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 18, 2020 Sale$42.1494,6003,986,59620,241,502Jun 22, 2020, 06:25 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 15, 2020 Sale$42.14129,1545,442,88520,597,932Jun 17, 2020, 06:13 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 17, 2020 Sale$42.1887,3193,683,48220,336,102Jun 17, 2020, 06:13 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 16, 2020 Sale$42.20174,5117,364,67920,423,421Jun 17, 2020, 06:13 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 04, 2020 Sale$47.111,81885,63820,727,086Jun 05, 2020, 05:43 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerJun 03, 2020 Sale$47.40487,40223,102,51421,002,984Jun 05, 2020, 05:43 PM
Belldegrun ArieDirectorJun 04, 2020 Buy$47.00146,3826,879,9541,798,163Jun 04, 2020, 04:04 PM
MOORE ALISONChief Technical OfficerMar 16, 2020 Sale$19.193,75071,98063,021Mar 18, 2020, 04:32 PM
SCHMIDT ERIC THOMASChief Financial OfficerMar 16, 2020 Sale$19.735,450107,50847,906Mar 18, 2020, 04:32 PM
Chang David DPresident and CEOMar 16, 2020 Sale$19.3120,335392,6152,215,426Mar 18, 2020, 04:31 PM
SCHMIDT ERIC THOMASChief Financial OfficerFeb 20, 2020 Option Exercise$25.30237,1556,000,0211,227,595Feb 24, 2020, 05:14 PM
MOORE ALISONChief Technical OfficerSep 16, 2019 Option Exercise$2.275,25711,93371,324Sep 18, 2019, 07:05 PM
MOORE ALISONChief Technical OfficerSep 18, 2019 Option Exercise$2.2721,06747,82287,134Sep 18, 2019, 07:05 PM
MOORE ALISONChief Technical OfficerSep 17, 2019 Option Exercise$2.2722,50351,08288,570Sep 18, 2019, 07:05 PM
MOORE ALISONChief Technical OfficerSep 18, 2019 Sale$32.1321,067676,87266,067Sep 18, 2019, 07:05 PM
MOORE ALISONChief Technical OfficerSep 17, 2019 Sale$32.1122,503722,56066,067Sep 18, 2019, 07:05 PM
MOORE ALISONChief Technical OfficerSep 16, 2019 Sale$32.005,257168,23466,067Sep 18, 2019, 07:05 PM
MOORE ALISONChief Technical OfficerJul 26, 2019 Option Exercise$2.2713,19329,94878,566Jul 30, 2019, 06:23 PM
MOORE ALISONChief Technical OfficerJul 30, 2019 Option Exercise$2.2711,81926,82977,192Jul 30, 2019, 06:23 PM
MOORE ALISONChief Technical OfficerJul 29, 2019 Option Exercise$2.2723,81554,06089,188Jul 30, 2019, 06:23 PM
MOORE ALISONChief Technical OfficerJul 30, 2019 Sale$29.8411,819352,73865,373Jul 30, 2019, 06:23 PM
MOORE ALISONChief Technical OfficerJul 29, 2019 Sale$29.3923,815699,87065,373Jul 30, 2019, 06:23 PM
MOORE ALISONChief Technical OfficerJul 26, 2019 Sale$29.1813,193384,99465,373Jul 30, 2019, 06:23 PM
MOORE ALISONChief Technical OfficerJun 28, 2019 Option Exercise$2.2727,81663,14265,373Jul 01, 2019, 04:32 PM
MOORE ALISONChief Technical OfficerJun 03, 2019 Option Exercise$2.2748,828110,84086,385Jun 05, 2019, 05:49 PM
MOORE ALISONChief Technical OfficerJun 03, 2019 Sale$26.7648,8281,306,77439,180Jun 05, 2019, 05:49 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerMay 14, 2019 Sale$29.381,918,75556,373,02021,216,306May 15, 2019, 04:07 PM
Belldegrun ArieDirectorOct 15, 2018 Buy$18.00194,4453,500,0101,691,781Feb 13, 2019, 05:10 PM
WITTE OWEN N.DirectorOct 15, 2018 Buy$18.0015,000270,000198,750Oct 17, 2018, 05:32 PM
Humer Franz BDirectorOct 15, 2018 Buy$18.0030,000540,00030,000Oct 17, 2018, 05:32 PM
Chang David DPresident and CEOOct 15, 2018 Buy$18.0040,000720,0001,995,625Oct 17, 2018, 05:30 PM
Belldegrun ArieDirectorOct 15, 2018 Buy$18.0035,000630,00035,000Oct 17, 2018, 05:29 PM
PFIZER INC10% OwnerOct 15, 2018 Buy$18.0055,5561,000,00822,032,040Oct 17, 2018, 05:17 PM
TPG Group Holdings (SBS) Advisors, Inc.10% OwnerOct 15, 2018 Buy$18.00675,00012,150,00023,135,061Oct 17, 2018, 05:10 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Chang David DPresident and CEO03/14/2024231,192
Parker Geoffrey M.CHIEF FINANCIAL OFFICER01/30/2024683
Roberts ZacharyEVP of R&D01/22/202478,376
MESSEMER DEBORAH M.Director12/18/202350,317
Mayo StephenDirector08/07/202342,855
Chang David DPresident and CEO03/14/2023124,210
SCHMIDT ERIC THOMASChief Financial Officer03/14/2023196,258
MOORE ALISONChief Technical Officer03/14/202345,990
Bhavnagri VeerGeneral Counsel03/14/2023133,971
Bhavnagri VeerGeneral Counsel02/13/202320,550
Bhavnagri VeerGeneral Counsel01/17/202321,120
Bhavnagri VeerGeneral Counsel12/15/202242,186
Amado RafaelEVP of R&D10/07/2022100,099
Amado RafaelEVP of R&D10/03/202299,201
WITTE OWEN N.Director08/12/202286,250
WITTE OWEN N.Director08/11/2022165,000
WITTE OWEN N.Director08/12/202286,250
WITTE OWEN N.Director08/11/2022165,000
Amado RafaelEVP of R&D and CMO08/02/202223,940
Amado RafaelEVP of R&D and CMO07/05/202222,880
WITTE OWEN N.Director06/22/2022117,600
Amado RafaelEVP of R&D and CMO06/21/202222,360
Amado RafaelEVP of R&D and CMO05/19/202285,092
Amado RafaelEVP of R&D and CMO03/15/202239,848
Bhavnagri VeerGeneral Counsel03/15/202267,962
Chang David DPresident and CEO03/15/2022180,879
SCHMIDT ERIC THOMASChief Financial Officer03/15/202287,551
MOORE ALISONChief Technical Officer03/15/202266,388
Kazam Joshua ADirector01/12/2022189,000
Belldegrun ArieDirector01/12/20221,953,491
Amado RafaelEVP of R&D and CMO10/01/2021280,185
Bhavnagri VeerGeneral Counsel09/15/202111,350
Bhavnagri VeerGeneral Counsel09/15/2021123,844
WITTE OWEN N.Director09/09/2021127,700
WITTE OWEN N.Director08/20/2021234,700
Bhavnagri VeerGeneral Counsel08/16/202111,350
Bhavnagri VeerGeneral Counsel08/16/2021104,994
Bhavnagri VeerGeneral Counsel07/15/202111,350
Bhavnagri VeerGeneral Counsel07/15/2021107,753
WITTE OWEN N.Director06/09/2021249,723
SCHMIDT ERIC THOMASChief Financial Officer05/24/2021271,423
Belldegrun ArieDirector05/24/20216,906,582
Amado RafaelEVP of R&D and CMO03/15/2021106,471
Chang David DPresident and CEO03/15/2021791,271
MOORE ALISONChief Technical Officer03/15/2021235,089
Bhavnagri VeerGeneral Counsel03/15/202122,700
Bhavnagri VeerGeneral Counsel03/15/2021630,798
SCHMIDT ERIC THOMASChief Financial Officer03/15/2021307,889
SCHMIDT ERIC THOMASChief Financial Officer01/15/2021483,859
SCHMIDT ERIC THOMASChief Financial Officer01/14/2021461,610
Bhavnagri VeerGeneral Counsel12/17/2020116,905
SCHMIDT ERIC THOMASChief Financial Officer11/16/2020493,146
SCHMIDT ERIC THOMASChief Financial Officer10/15/2020607,392
MOORE ALISONChief Technical Officer10/12/202055,009
MOORE ALISONChief Technical Officer10/13/202025,040
MOORE ALISONChief Technical Officer10/13/2020463,302
MOORE ALISONChief Technical Officer10/12/20201,017,786
MOORE ALISONChief Technical Officer10/09/202068,552
MOORE ALISONChief Technical Officer10/08/202011,498
MOORE ALISONChief Technical Officer10/09/20201,619,869
MOORE ALISONChief Technical Officer10/08/2020207,665
Amado RafaelEVP of R&D and CMO10/07/2020651,515
MOORE ALISONChief Technical Officer10/06/202080,049
MOORE ALISONChief Technical Officer10/06/20201,782,960
Bhavnagri VeerGeneral Counsel10/06/202022,700
Bhavnagri VeerGeneral Counsel10/06/2020400,000
Bhavnagri VeerGeneral Counsel10/01/202056,750
Bhavnagri VeerGeneral Counsel10/01/2020912,913
Amado RafaelEVP of R&D and CMO10/01/2020354,662
SCHMIDT ERIC THOMASChief Financial Officer09/21/2020529,545
Bhavnagri VeerGeneral Counsel09/01/202056,750
Bhavnagri VeerGeneral Counsel09/01/2020883,966
MOORE ALISONChief Technical Officer08/13/202073,664
TPG Group Holdings (SBS) Advisors, Inc.10% Owner08/07/2020497,236
TPG Group Holdings (SBS) Advisors, Inc.10% Owner08/06/2020905,794
Bhavnagri VeerGeneral Counsel08/03/202056,750
Bhavnagri VeerGeneral Counsel08/03/20201,164,121
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/30/20202,522,052
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/29/20201,077,544
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/26/202022,005
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/24/2020670,714
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/23/20205,814,610
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/25/20203,197,327
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/22/20207,384,721
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/19/20202,008,306
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/18/20203,986,596
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/15/20205,442,885
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/17/20203,683,482
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/16/20207,364,679
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/04/202085,638
TPG Group Holdings (SBS) Advisors, Inc.10% Owner06/03/202023,102,514
Belldegrun ArieDirector06/04/20206,879,954
MOORE ALISONChief Technical Officer03/16/202071,980
SCHMIDT ERIC THOMASChief Financial Officer03/16/2020107,508
Chang David DPresident and CEO03/16/2020392,615
SCHMIDT ERIC THOMASChief Financial Officer02/20/20206,000,021
MOORE ALISONChief Technical Officer09/16/201911,933
MOORE ALISONChief Technical Officer09/18/201947,822
MOORE ALISONChief Technical Officer09/17/201951,082
MOORE ALISONChief Technical Officer09/18/2019676,872
MOORE ALISONChief Technical Officer09/17/2019722,560
MOORE ALISONChief Technical Officer09/16/2019168,234
MOORE ALISONChief Technical Officer07/26/201929,948
MOORE ALISONChief Technical Officer07/30/201926,829
MOORE ALISONChief Technical Officer07/29/201954,060
MOORE ALISONChief Technical Officer07/30/2019352,738
MOORE ALISONChief Technical Officer07/29/2019699,870
MOORE ALISONChief Technical Officer07/26/2019384,994
MOORE ALISONChief Technical Officer06/28/201963,142
MOORE ALISONChief Technical Officer06/03/2019110,840
MOORE ALISONChief Technical Officer06/03/20191,306,774
TPG Group Holdings (SBS) Advisors, Inc.10% Owner05/14/201956,373,020
Belldegrun ArieDirector10/15/20183,500,010
WITTE OWEN N.Director10/15/2018270,000
Humer Franz BDirector10/15/2018540,000
Chang David DPresident and CEO10/15/2018720,000
Belldegrun ArieDirector10/15/2018630,000
PFIZER INC10% Owner10/15/20181,000,008
TPG Group Holdings (SBS) Advisors, Inc.10% Owner10/15/201812,150,000
Load More Insider Transactions
FUNDS WITH A POSITION IN ALLOGENE THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.10,001,8040.00082%12.46%Other
GEODE CAPITAL MANAGEMENT, LLC2,335,1950.00078%12.74%Other
RENAISSANCE TECHNOLOGIES LLC458,6480.00228%1414.59%Other
D. E. SHAW & CO., INC.75,6400.00021%-39.12%Other
ALPS ADVISORS INC118,6540.00299%-4.09%Other
TUDOR INVESTMENT CORP ET AL73,9980.00235%ExitedEvent Driven, Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)28,1690.00167%NewOther
BALYASNY ASSET MANAGEMENT L.P.15,7300.00009%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR ALLOGENE THERAPEUTICS INC
STOCK BUYBACKS FOR ALLOGENE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.49%
1Q
12/31/2023
06/30/2023
14.76%
2Q
12/31/2023
03/31/2023
16.53%
3Q
12/31/2023
12/31/2022
16.86%
4Q
12/31/2023
09/30/2022
17.26%
5Q
12/31/2023
06/30/2022
17.49%
6Q
12/31/2023
03/31/2022
19.18%
7Q
12/31/2023
12/31/2021
21.01%
8Q
12/31/2023
09/30/2021
22.94%
9Q
12/31/2023
06/30/2021
24.95%
10Q
12/31/2023
03/31/2021
27.47%
11Q
12/31/2023
12/31/2020
29.79%
12Q
12/31/2023
09/30/2020
32.50%
13Q
12/31/2023
06/30/2020
46.01%
14Q
12/31/2023
03/31/2020
54.61%
15Q
12/31/2023
12/31/2019
60.69%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.49%
1Q
06/30/2023
14.76%
2Q
03/31/2023
16.53%
3Q
12/31/2022
16.86%
4Q
09/30/2022
17.26%
5Q
06/30/2022
17.49%
6Q
03/31/2022
19.18%
7Q
12/31/2021
21.01%
8Q
09/30/2021
22.94%
9Q
06/30/2021
24.95%
10Q
03/31/2021
27.47%
11Q
12/31/2020
29.79%
12Q
09/30/2020
32.50%
13Q
06/30/2020
46.01%
14Q
03/31/2020
54.61%
15Q
12/31/2019
60.69%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ALLOGENE THERAPEUTICS INC
LOADING...